{"data":{"id":"us/21-cfr-333.280","jurisdiction":"us","citation":"21 CFR 333.280","heading":"Professional labeling.","body":"The labeling provided to health professionals (but not to the general public) may contain the following additional indication:\n(a) For products containing haloprogin or miconazole nitrate identified in § 333.210 (a) and (c). “For the treatment of superficial skin infections caused by yeast (Candida albicans).”\n(b) [Reserved]","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 333—TOPICAL ANTIMICROBIAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE","Subpart C—Topical Antifungal Drug Products"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"12a95324bae5d1d35828df8700f8cdd06bc5c506e8d6271f4dcb29c12cf9eeb7","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-333.250","next":"us/21-cfr-333.301"},"notice":"GroundRules: Original legal text. Not legal advice."}